Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt L Kosel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
World Neurosurgery|April 10, 2012
Mortality and discharge to home after closed brain biopsy: analysis of 3523 cases from the State of California, 2003-2009Derek R Johnson, Brian P O'Neill, Paul A Decker, et al.
Neuro-Oncology|February 28, 2026
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytomaKristen L Drucker, Arijit Panda, Paul A Decker, et al.
Neuro-Oncology Advances|February 10, 2026
Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenograftsRachael A Vaubel, Wenjuan Zhang, Nishika Karbhari, et al.
Genetic Epidemiology|January 3, 2013
Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studiesKyle M Walsh, Erik Anderson, Helen M Hansen, et al.
Neuro-Oncology|May 10, 2020
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20CJeanette E Eckel-Passow, Kristen L Drucker, Thomas M Kollmeyer, et al.
Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
World Neurosurgery|April 10, 2012
Mortality and discharge to home after closed brain biopsy: analysis of 3523 cases from the State of California, 2003-2009Derek R Johnson, Brian P O'Neill, Paul A Decker, et al.
Neuro-Oncology|February 28, 2026
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytomaKristen L Drucker, Arijit Panda, Paul A Decker, et al.
Neuro-Oncology Advances|February 10, 2026
Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenograftsRachael A Vaubel, Wenjuan Zhang, Nishika Karbhari, et al.
Genetic Epidemiology|January 3, 2013
Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studiesKyle M Walsh, Erik Anderson, Helen M Hansen, et al.
Neuro-Oncology|May 10, 2020
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20CJeanette E Eckel-Passow, Kristen L Drucker, Thomas M Kollmeyer, et al.
Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Pageof 1